From Yahoo Finance: 2025-06-23 01:39:00

10x Genomics, Inc. settles patent dispute with Bruker, receiving $68 million in quarterly installments from Q3 2025 to Q2 2026. Bruker will pay continuous royalties on spatial biology product sales and both companies agree to global patent cross-licenses, ending legal actions in the US, Germany, and the European Unified Patent Court.

10x Genomics emphasizes intellectual property protection for scientific innovation, CEO Serge Saxonov sees settlement as validation of company vision. Chief Legal Officer Eric Whitaker highlights robustness of IP portfolio in spatial biology, settlement allows for continued funding of innovations. No promotional content in the article.



Read more at Yahoo Finance: 10x Genomics Settles Patent Dispute With Bruker